Indefinite Delivery Contract 36C24223D0045

Award Date 2/22/23
Last Date to Order 2/21/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This federal contract IDV award is for the supply of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA) healthcare system. The prime contractor, Nuclear Diagnostic Products, Inc., is a for-profit organization specializing in providing critical medical imaging compounds used in nuclear medicine diagnostic procedures such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT) scans. The contract, which does not have a small business set-aside...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 (VA VHA VISN 2) awarded a single award indefinite delivery contract to Nuclear Diagnostic Products, Inc. to provide general radiopharmaceuticals. Under the contract, two firm fixed price delivery orders were issued for approximately $1.9 million and $2.2 million respectively to supply radiopharmaceutical products to VA medical centers in New York and New Jersey. The delivery orders have a...
The Department of Veterans Affairs (VA), Network Contracting Office 6, awarded a single-award Indefinite Delivery Contract (IDC) to Petnet Solutions, Inc., a subsidiary of Siemens AG, to provide specialized radiopharmaceutical supplies. The $2.9 million IDC, awarded on March 1, 2024, has a period of performance through February 28, 2026. Under this IDC, the VA issued a $630,728 firm fixed-price delivery order for the supply of FDG, Axumin, Amyvid, and Tauvid radioactive tracers and calibration...
The U.S. Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, for the supply of nuclear medicine radiopharmaceuticals. The IDC, with a ceiling value of $1,500,000, has a performance period of April 27, 2023 to April 26, 2028. Under this IDC, the VA has issued several firm-fixed-price delivery orders to Jubilant Radiopharma for the...
The Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network 16 (VISN 16) has awarded an Indefinite Delivery Contract (IDC) to Numedrx Pharmacy Solutions LLC, a self-certified small disadvantaged business, to provide radiopharmaceutical supplies. This $2,692,693.25 single-award IDC, with a period of performance through September 2025, allows VISN 16 to issue firm fixed price delivery orders as needed to procure critical radiopharmaceutical products...
This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business. The $950,000 single-award IDC covers the provision of nuclear radiopharmaceuticals to support medical operations for the VA's Veterans Integrated Service Network (VISN) 21. Under this IDC, Jubilant Radiopharma has received multiple firm fixed-price delivery orders to...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, for the procurement of nuclear medicine radiopharmaceuticals. The single-award IDC has a total contract ceiling of $220,000 and a performance period running through March 31, 2030. Jubilant Radiopharma, a for-profit small disadvantaged business, will provide a range of specialized...
The Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The $2.29 million single-award IDC, with a period of performance through January 2030, is for the supply of radiopharmaceuticals, including specialized medical isotopes, diagnostic imaging agents, and therapeutic radioisotopes, to support nuclear medicine procedures, PET scans,...
This federal contract IDV is awarded by the U.S. Department of Veterans Affairs (VA) to Pharmalogic WV LTD, a for-profit manufacturer and supplier of radiopharmaceuticals based in Bridgeport, West Virginia. The IDV, valued at $433,057.86, is a single-award contract with the VA's Veterans Integrated Service Network (VISN) 5 to provide a comprehensive range of radiopharmaceutical products, including isotopes, generators, and imaging agents, to support nuclear medicine diagnostics and treatment for...
This Indefinite Delivery Contract (IDC) award to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) was issued by the U.S. Department of Veterans Affairs (VA) for the provision of radiopharmaceuticals. The single-award IDC, valued at a ceiling of $800,000, has an ultimate completion date of June 30, 2030 and was awarded on July 1, 2025. The contract supports the VA's procurement of a range of nuclear medicine products, including Ga-68 Dotatate, iodine I-123,...
  • 36C24223D0045
    Indefinite Delivery Contract
  • 8
    Federal Contract Awards

The U.S. Department of Veterans Affairs (VA) awarded an Indefinite Delivery Contract (IDC) to Nuclear Diagnostic Products, Inc., a for-profit radiopharmaceutical supplier, to provide general radiopharmaceuticals to support nuclear medicine imaging procedures for the VA's Veterans Integrated Service Network (VISN) 2 healthcare system. The $4,038,178.15 IDC, which does not have a set-aside designation, has a period of performance through February 2026. Multiple firm fixed-price delivery orders have been issued against this IDC, ranging from $51,680.50 to $995,667.70, to supply critical radiopharmaceutical products, such as ILLUCCIX and GA-68 NETSPOT, to VA medical facilities primarily located in New York and New Jersey. Nuclear Diagnostic Products, Inc. has also been awarded similar IDCs with the VA to support radiopharmaceutical needs across other VISNs, demonstrating its ability to consistently provide specialized medical imaging compounds essential for veteran healthcare diagnostics.

The original solicitation for the VISN 2 Downstate General Radiopharmaceuticals contract did not have a set-aside designation. The contract aims to procure a range of general radiopharmaceuticals used in nuclear medicine procedures, including positron emission tomography (PET) and single-photon emission computed tomography (SPECT) scans, to support the VA's diagnostic imaging services for veterans in the northeastern United States. The contracted products and services are intended to be delivered to the company's facility in Rockaway, New Jersey, and then distributed to VA medical centers within VISN 2.

Generated 5/9/25, 10:14 AM